These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 34392300)
21. Diagnosis and management of autonomic failure in neurodegenerative disorders. Sambati L; Calandra-Buonaura G; Doria A; Cortelli P Eur Neurol; 2015; 73(1-2):126-33. PubMed ID: 25503740 [TBL] [Abstract][Full Text] [Related]
22. Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathies. Goldstein DS; Holmes C; Sharabi Y Brain; 2012 Jun; 135(Pt 6):1900-13. PubMed ID: 22451506 [TBL] [Abstract][Full Text] [Related]
23. Pure Autonomic Failure-A Localized Alpha Synucleinopathy with a Potential for Conversion to More Extensive Alpha Synucleinopathies. Bhattacharjee S; Alsukhni RA Ann Indian Acad Neurol; 2022; 25(3):340-346. PubMed ID: 35936586 [TBL] [Abstract][Full Text] [Related]
26. Can novel non-invasive autonomic tests help discriminate between pure autonomic failure and multiple system atrophy? Gagaouzova BS; Datema M; Thijs RD; Tannemaat MR; Steenmeijer SR; Notting IC; van Dijk JG Auton Neurosci; 2021 Mar; 231():102773. PubMed ID: 33548868 [TBL] [Abstract][Full Text] [Related]
27. Biofluid Detection of Pathological α-Synuclein in the Prodromal Phase of Synucleinopathies. Kluge A; Iranzo A J Parkinsons Dis; 2024 Jul; ():. PubMed ID: 38995801 [TBL] [Abstract][Full Text] [Related]
28. Are We Ready for Detecting α-Synuclein Prone to Aggregation in Patients? The Case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as Diagnostic Tools. Paciotti S; Bellomo G; Gatticchi L; Parnetti L Front Neurol; 2018; 9():415. PubMed ID: 29928254 [TBL] [Abstract][Full Text] [Related]
29. Abnormal dopamine transporter imaging in pure autonomic failure: a potential biomarker of central nervous system involvement. Alnasser Alsukhni R; Vichayanrat E; Koay S; Davis LM; Ingle G; McNamara P; Panicker JN; Bhatia KP; Mathias C; Bomanji J; Iodice V Eur J Neurol; 2024 Mar; 31(3):e16169. PubMed ID: 38085264 [TBL] [Abstract][Full Text] [Related]
30. Skin nerve α-synuclein deposits in Parkinson's disease and other synucleinopathies: a review. Donadio V Clin Auton Res; 2019 Dec; 29(6):577-585. PubMed ID: 30506233 [TBL] [Abstract][Full Text] [Related]
31. Patterns of neuropathy and autonomic failure in patients with amyloidosis. Wang AK; Fealey RD; Gehrking TL; Low PA Mayo Clin Proc; 2008 Nov; 83(11):1226-30. PubMed ID: 18990321 [TBL] [Abstract][Full Text] [Related]
32. Updates on the Diagnosis and Treatment of Peripheral Autonomic Neuropathies. Lamotte G; Sandroni P Curr Neurol Neurosci Rep; 2022 Dec; 22(12):823-837. PubMed ID: 36376534 [TBL] [Abstract][Full Text] [Related]
35. Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies. Villar-Piqué A; Lopes da Fonseca T; Outeiro TF J Neurochem; 2016 Oct; 139 Suppl 1():240-255. PubMed ID: 26190401 [TBL] [Abstract][Full Text] [Related]
36. Moving forward the in vivo diagnosis of the synucleinopathies. Vilas D Clin Auton Res; 2019 Dec; 29(6):575-576. PubMed ID: 30721384 [No Abstract] [Full Text] [Related]
37. Synuclein in neurodegeneration. Bougea A Adv Clin Chem; 2021; 103():97-134. PubMed ID: 34229853 [TBL] [Abstract][Full Text] [Related]
38. The clinical approach to autonomic failure in neurological disorders. Benarroch EE Nat Rev Neurol; 2014 Jul; 10(7):396-407. PubMed ID: 24866874 [TBL] [Abstract][Full Text] [Related]
39. Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis. Jain S; Goldstein DS Neurobiol Dis; 2012 Jun; 46(3):572-80. PubMed ID: 22094370 [TBL] [Abstract][Full Text] [Related]
40. Divergent development of autonomic and peripheral somatic neuropathies in NIDDM. Töyry JP; Partanen JV; Niskanen LK; Länsimies EA; Uusitupa MI Diabetologia; 1997 Aug; 40(8):953-8. PubMed ID: 9267991 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]